CL2014003632A1 - Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer. - Google Patents

Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer.

Info

Publication number
CL2014003632A1
CL2014003632A1 CL2014003632A CL2014003632A CL2014003632A1 CL 2014003632 A1 CL2014003632 A1 CL 2014003632A1 CL 2014003632 A CL2014003632 A CL 2014003632A CL 2014003632 A CL2014003632 A CL 2014003632A CL 2014003632 A1 CL2014003632 A1 CL 2014003632A1
Authority
CL
Chile
Prior art keywords
peritoneal
pleural
washes
systemic
origin
Prior art date
Application number
CL2014003632A
Other languages
English (en)
Inventor
Gareth Ivor Owen
Castillo María Loreto Bravo
Cardemil Sumie Rode Kato
Fredes Mauricio Arturo Cuello
Walden Renán Felipe Orellana
Hevia Pamela Andrea González
Original Assignee
Pontificia Universidad Católica De Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Católica De Chile filed Critical Pontificia Universidad Católica De Chile
Priority to CL2014003632A priority Critical patent/CL2014003632A1/es
Publication of CL2014003632A1 publication Critical patent/CL2014003632A1/es
Priority to PCT/IB2015/059019 priority patent/WO2016108099A2/es
Priority to ARP150104319A priority patent/AR103303A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CL2014003632A 2014-12-31 2014-12-31 Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer. CL2014003632A1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CL2014003632A CL2014003632A1 (es) 2014-12-31 2014-12-31 Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer.
PCT/IB2015/059019 WO2016108099A2 (es) 2014-12-31 2015-11-20 Método que comprende el cultivo y expansión de células presentes en el líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer
ARP150104319A AR103303A1 (es) 2014-12-31 2015-12-28 Método que comprende el cultivo y expansión de células presentes en el líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003632A CL2014003632A1 (es) 2014-12-31 2014-12-31 Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer.

Publications (1)

Publication Number Publication Date
CL2014003632A1 true CL2014003632A1 (es) 2015-06-26

Family

ID=56613937

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003632A CL2014003632A1 (es) 2014-12-31 2014-12-31 Método que comprende el cultivo y expansión de células presentes en líquido ascítico de origen peritoneal, pleural, lavado peritoneal o lavados sistémicos que permite determinar el mejor tratamiento para pacientes con cáncer.

Country Status (3)

Country Link
AR (1) AR103303A1 (es)
CL (1) CL2014003632A1 (es)
WO (1) WO2016108099A2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980703088A (ko) * 1995-03-16 1998-09-05 라카일레 지, 필리페 신규의 침전탄산칼슘 안료를 포함하는 잉크젯 기록지
EP2207892A4 (en) * 2007-10-15 2010-12-08 Precision Therapeutics Inc METHOD FOR SELECTION OF ACTIVE AGENTS FOR CANCER TREATMENT
US20140087362A1 (en) * 2012-03-16 2014-03-27 Aladar A. Szalay Methods for assessing effectiveness and monitoring oncolytic virus treatment
US9580678B2 (en) * 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device

Also Published As

Publication number Publication date
AR103303A1 (es) 2017-05-03
WO2016108099A2 (es) 2016-07-07
WO2016108099A3 (es) 2016-08-18

Similar Documents

Publication Publication Date Title
IL282352B (en) Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereof
IL283733A (en) Methods of cancer treatment using activated t cells
IL271242B (en) Systems and methods of content transaction consensus
IL259162B (en) Fgfr2 inhibitors alone or in combination with immune stimulating agents in cancer treatment
IL254294A0 (en) Topical regional neuro-affective therapy with cannabinoids
HUE057817T2 (hu) Anti-LAG-3 antitestek haematológiai malignitások kezelésére
SI3331915T1 (sl) Zaviralci kontrolnih točk za uporabo v zdravljenju rakov, ki se prenašajo s krvjo
SI3142751T1 (sl) Protitelesa proti-B7-H1 in proti-CTLA-4 za zdravljenje nedrobnoceličnega pljučnega raka
PL3198033T3 (pl) Zastosowanie paneli zmutowanych genów fgfr w identyfikacji pacjentów z nowotworem, którzy będą reagowali na leczenie inhibitorem fgfr
IL252361A0 (en) Compositions and methods for treating and diagnosing chemotherapy-resistant cancers
MX2016002137A (es) Ciertas entidades quimicas, composiciones y metodos.
DK3693158T3 (da) Asymmetrisk forarbejdningsfremgangsmåde til krumningsreduktion i laminatstrukturer
PL3140097T3 (pl) Korpus wielowarstwowy i sposób jego wytwarzania
ME03558B (me) Molekuli anti-lag-3 antiтela i njihove upotrebe
DK3067404T3 (da) Fremgangsmåder til anvendelse i olie- og/eller gaskilder
SI3218005T1 (sl) Z glikanom delujoče spojine, in postopki uporabe
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
MX372823B (es) Derivados de ácido borónico.
DK3356575T3 (da) Højtryks- eller differenstrykelektrolysecelle
MX2016011022A (es) Metodo para el tratamiento de depositos subterraneos.
BR112017008799A2 (pt) composições de apilimod e métodos de uso das mesmas no tratamento de câncer renal
DK3779120T3 (da) Kemiske varmekilder til anvendelse i borehuloperationer
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
PL3174510T3 (pl) Sposób i wyrób do utrzymania płynu menstruacyjnego wewnątrz pochwy
PL3978074T3 (pl) Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1